Tumani H - Search Results

1

Neurofilaments as biomarkers in neurological disorders - towards clinical application.

Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T, Bittner S, Sormani MP, Gattringer T, Abu-Rumeileh S, Thebault S, Abdelhak A, Green A, Benkert P, Kappos L, Comabella M, Tumani H, Freedman MS, Petzold A, Blennow K, Zetterberg H, Leppert D, Kuhle J. Khalil M, et al. Among authors: tumani h. Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12. Nat Rev Neurol. 2024. PMID: 38609644 Review.

2

The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.

Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, Tumani H. Brettschneider J, et al. Among authors: tumani h. Dement Geriatr Cogn Disord. 2006;21(5-6):291-5. doi: 10.1159/000091436. Epub 2006 Feb 10. Dement Geriatr Cogn Disord. 2006. PMID: 16484807

3

Axonal damage markers in cerebrospinal fluid are increased in ALS.

Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H. Brettschneider J, et al. Among authors: tumani h. Neurology. 2006 Mar 28;66(6):852-6. doi: 10.1212/01.wnl.0000203120.85850.54. Neurology. 2006. PMID: 16567701

4

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.

Brettschneider J, Petzold A, Junker A, Tumani H. Brettschneider J, et al. Among authors: tumani h. Mult Scler. 2006 Apr;12(2):143-8. doi: 10.1191/135248506ms1263oa. Mult Scler. 2006. PMID: 16629417

5

Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.

Brettschneider J, Petzold A, Süssmuth SD, Landwehrmeyer GB, Ludolph AC, Kassubek J, Tumani H. Brettschneider J, et al. Among authors: tumani h. Mov Disord. 2006 Dec;21(12):2224-7. doi: 10.1002/mds.21124. Mov Disord. 2006. PMID: 17013909

6

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.

Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R; BENEFIT investigators. Polman C, et al. J Neurol. 2008 Apr;255(4):480-7. doi: 10.1007/s00415-007-0733-2. Epub 2007 Nov 15. J Neurol. 2008. PMID: 18004635 Clinical Trial.

7

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.

Tumani H, Teunissen C, Süssmuth S, Otto M, Ludolph AC, Brettschneider J. Tumani H, et al. Expert Rev Mol Diagn. 2008 Jul;8(4):479-94. doi: 10.1586/14737159.8.4.479. Expert Rev Mol Diagn. 2008. PMID: 18598229 Review.

8

TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, Pabst A, Uttner I, Tumani H, Lee VM, Trojanowski JQ, Kretzschmar HA, Ludolph A, Neumann M, Otto M. Steinacker P, et al. Among authors: tumani h. Arch Neurol. 2008 Nov;65(11):1481-7. doi: 10.1001/archneur.65.11.1481. Arch Neurol. 2008. PMID: 19001167 Free PMC article.

9

Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Brettschneider J, Petzold A, Süssmuth S, Tumani H. Brettschneider J, et al. Among authors: tumani h. J Neurol. 2009 Jan;256(1):3-12. doi: 10.1007/s00415-009-0097-x. Epub 2009 Feb 16. J Neurol. 2009. PMID: 19267167 Review.

10

Cerebrospinal fluid biomarkers in multiple sclerosis.

Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK; BioMS Study Group. Tumani H, et al. Neurobiol Dis. 2009 Aug;35(2):117-27. doi: 10.1016/j.nbd.2009.04.010. Epub 2009 May 5. Neurobiol Dis. 2009. PMID: 19426803 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page